These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1026342)

  • 1. Role of radioautographic studies in clinical investigative oncology and chemotherapy.
    Shackney SE
    Cancer Treat Rep; 1976 Dec; 60(12):1873-86. PubMed ID: 1026342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell kinetics and chemotherapy: a critical review.
    Tannock I
    Cancer Treat Rep; 1978 Aug; 62(8):1117-33. PubMed ID: 356975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible significance of nonproliferating leukemic cells.
    Mauer AM; Saunders EF; Lampkin C
    Natl Cancer Inst Monogr; 1969 May; 30():63-79. PubMed ID: 5351830
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid in vitro labeling index method for predicting response of human solid tumors to chemotherapy.
    Thirlwell MP; Livingston RB; Murphy WK; Hart JS
    Cancer Res; 1976 Sep; 36(9 pt.1):3279-83. PubMed ID: 975089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical drug development: an analysis of phase II trials, 1970-1985.
    Marsoni S; Hoth D; Simon R; Leyland-Jones B; De Rosa M; Wittes RE
    Cancer Treat Rep; 1987 Jan; 71(1):71-80. PubMed ID: 3791270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro determination of thymidine-3H labeling index in human solid tumors.
    Livingston RB; Ambus U; George SL; Freireich EJ; Hart JS
    Cancer Res; 1974 Jun; 34(6):1376-80. PubMed ID: 4363655
    [No Abstract]   [Full Text] [Related]  

  • 10. Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval.
    Goffin J; Baral S; Tu D; Nomikos D; Seymour L
    Clin Cancer Res; 2005 Aug; 11(16):5928-34. PubMed ID: 16115935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation kinetics in benign and malignant skin diseases in humans.
    Weinstein GD; Frost P
    Natl Cancer Inst Monogr; 1969 May; 30():225-46. PubMed ID: 5361648
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferative activity and radiosensitivity of human tumors.
    Karakulov RK; Potapov SL; Kachkov IA; Polyakov PY; Kiseleva ES; Daryalova SL; Saenko AS; Simakina EP; Pelevina II
    Neoplasma; 1982; 29(5):579-87. PubMed ID: 7177248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell population kinetics and chemotherapy. I. The kinetics of tumor cell populations.
    Steel GG; Lamerton LF
    Natl Cancer Inst Monogr; 1969 May; 30():29-42. PubMed ID: 5351827
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
    Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
    Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of DNA synthesis by 3H-thymidine incorporation into needle aspirates from human tumors.
    Nordenskjöld B; Zetterberg A; Löwhagen T
    Acta Cytol; 1974; 18(3):215-21. PubMed ID: 4525221
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical application of chronobiology to oncology.
    Hrushesky WJ
    Am J Anat; 1983 Dec; 168(4):519-42. PubMed ID: 6198896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH
    Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II oncology trials: let's be positive.
    Ratain MJ
    Clin Cancer Res; 2005 Aug; 11(16):5661-2. PubMed ID: 16115898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.